We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NEW FDA GUIDANCE OUTLINES 510(k) ASSESSMENT STEPS
NEW FDA GUIDANCE OUTLINES 510(k) ASSESSMENT STEPS
May 21, 2004
The FDA has released a new guidance updating industry on the effect various review actions have on Medical Device User Fee Modernization Act (MDUFMA) time goals during the premarket 510(k) submission process.